Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Metabolic strategy could tackle HIV reservoir, other infections

Dec. 21, 2018

EC grants approval to Delstrigo and Pifeltro for HIV-1 infection

Nov. 29, 2018

ViiV Healthcare presents HIV replication inhibitors

Nov. 28, 2018

Juluca approved in Japan

Nov. 26, 2018

NIH grant supports IBBR's development of antibody therapeutic against HIV-1

Nov. 20, 2018

Sleeper HIV can be napping or conked out

Nov. 20, 2018

Novel rBCG:HIV vaccine candidates with a ChAd.HIV boost show safety and immunogenicity in vivo

Nov. 13, 2018

Effects of tenofovir and tenofovir/levonorgestrel vaginal rings on vaginal microbiota and mucosal PK

Nov. 13, 2018

SCaV11 immunogen selectively elicits CD8+ T cells but not CD4+ T cells targeting viral antigens

Nov. 12, 2018

Combination of IDLV-SIV-Gag and IDLV-PGT121 results in prolonged virus control in vivo

Nov. 12, 2018

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...